Category: Life Sciences
Global Life Sciences
-
Surgical Kits
... CAGR of 7.5% over the analysis period 2024-2030. Disposable Surgical Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$22.6 Billion by the end of the ... Read More
-
Wheelchair Accessible Vehicle Converters
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Vans, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$7.2 Billion by the end ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Protective Eyewear
... CAGR of 4.6% over the analysis period 2024-2030. Non-Prescription Protective Eyewear, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Decontamination Systems
... CAGR of 5.3% over the analysis period 2024-2030. Defense End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.5 Billion by the end of the analysis ... Read More
-
Preparative and Process Chromatography
... 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Process Chromatography, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$8.9 Billion by the ... Read More
-
qPCR Reagents
... CAGR of 7.4% over the analysis period 2024-2030. Dye-Based qPCR Reagents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Livestock Monitoring
... CAGR of 9.5% over the analysis period 2024-2030. Livestock Monitoring Hardware, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Low VOC Paints
... at a CAGR of 5.8% over the analysis period 2024-2030. Water-Borne Formulation, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$10.7 Billion by the end of ... Read More
-
Peritoneal Dialysis
... CAGR of 5.7% over the analysis period 2024-2030. Continuous Ambulatory Peritoneal Dialysis (CAPD), one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.5 Billion by the end ... Read More
-
Peripheral Vascular Devices
... at a CAGR of 4.0% over the analysis period 2024-2030. Angioplasty Stents, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.1 Billion by the end of ... Read More
-
Precision Medicine Software
... at a CAGR of 10.0% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Ultrasound Image Analysis Software
... 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Integrated Software, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.2 Billion by the ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end ... Read More
-
X-ray Inspection Systems
... at a CAGR of 6.0% over the analysis period 2024-2030. Digital Imaging Technique, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$925.2 Million by the end ... Read More
-
Frozen Food
... CAGR of 6.5% over the analysis period 2024-2030. Frozen Raw Material, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$195.4 Billion by the end of the ... Read More
-
Handheld Surgical Instruments
... at a CAGR of 8.0% over the analysis period 2024-2030. Handheld Surgical Instruments, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$7.2 Billion by the end ... Read More
-
Hemostasis Valves
... CAGR of 6.9% over the analysis period 2024-2030. Y-Connectors, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$111.9 Million by the end of the analysis period. ... Read More
-
Meal Kit Delivery Services
... 2030, growing at a CAGR of 17.0% over the analysis period 2024-2030. Cook & Eat Meal Kit, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$42.1 ... Read More
-
Medical Elastomers
... CAGR of 7.1% over the analysis period 2024-2030. Thermoplastic Elastomers, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$9.4 Billion by the end of the analysis ... Read More
-
Mid-Revenue Cycle Management / Clinical Documentation Improvement
... expected to reach US$8.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Solutions Component, one of the segments analyzed in the report, is expected to record a 6.6% CAGR ... Read More
-
Endoscope Reprocessing
... CAGR of 7.9% over the analysis period 2024-2030. High-Level Disinfectants & Test Strips, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.4 Billion by the end ... Read More
-
Radiodermatitis
... 4.2% over the analysis period 2024-2030. Topical Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$412.0 Million by the end of the analysis period. Growth ... Read More
-
Self-Leveling Concrete
... CAGR of 4.3% over the analysis period 2024-2030. Underlayment, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$7.0 Billion by the end of the analysis period. ... Read More
-
Single-Cell Genome Sequencing
... at a CAGR of 13.6% over the analysis period 2024-2030. Single-Cell Genome Sequencing Instruments, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$4.5 Billion by the ... Read More